NAVCO Pharmaceuticals Inc. (TSXV:NAV)

NAVCO Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	0	0.01	0.23	0	0
Cash & Short-Term Investments	0	0.01	0.23	0	0
Cash Growth	-59.39%	-96.87%	15187.95%	-62.29%	-
Other Receivables	-	0.07	0.05	0.06	0.03
Receivables	-	0.07	0.05	0.06	0.03
Inventory	-	-	0	0	0.01
Prepaid Expenses	-	-	0.43	-	-
Total Current Assets	0	0.07	0.71	0.06	0.04
Property, Plant & Equipment	-	0	0.18	0.22	0.25
Other Intangible Assets	-	-	0.04	0.05	0.05
Total Assets	0	0.08	0.93	0.32	0.35
Accounts Payable	0.19	0.17	0.11	0.17	0.08
Accrued Expenses	0.04	0.03	0.13	0.04	0.01
Short-Term Debt	0.09	0.09	0.01	0.78	0.17
Current Portion of Leases	-	0.01	0.01	0.01	0.01
Other Current Liabilities	0.63	0.63	0.49	-	0.29
Total Current Liabilities	0.94	0.93	0.75	1.01	0.56
Long-Term Leases	-	-	0.09	0.1	0.12
Total Liabilities	0.94	0.93	0.84	1.11	0.67
Common Stock	4.02	4.02	3.35	0.88	0.88
Retained Earnings	-5.61	-5.53	-3.81	-1.66	-1.2
Comprehensive Income & Other	0.66	0.66	0.55	-	-
Shareholders' Equity	-0.94	-0.86	0.09	-0.79	-0.32
Total Liabilities & Equity	0	0.08	0.93	0.32	0.35
Total Debt	0.09	0.1	0.11	0.9	0.29
Net Cash (Debt)	-0.08	-0.09	0.12	-0.9	-0.29
Net Cash Per Share	-0.00	-0.00	0.00	-0.04	-0.02
Filing Date Shares Outstanding	57.07	57.07	40.35	14.5	14.48
Total Common Shares Outstanding	57.07	57.07	40.35	14.5	14.48
Working Capital	-0.94	-0.86	-0.04	-0.95	-0.52
Book Value Per Share	-0.02	-0.02	0.00	-0.05	-0.02
Tangible Book Value	-0.94	-0.86	0.05	-0.83	-0.38
Tangible Book Value Per Share	-0.02	-0.02	0.00	-0.06	-0.03
Machinery	0.03	0.03	0.1	0.1	0.1
Leasehold Improvements	0.04	0.04	0.05	0.05	0.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.